Annals of Surgery Volume 267, Number 3, March 2018 Letters to the Editor pancreatogastrostomy versus pancreaticojejunos- unfavorable tumor biology, which explains Traslational Medicine tomy after partial pancreatoduodenectomy. J Gas- the lack of survival advantage of reresec- Sapienza University, Rome, Italy trointest Surg. 2012;16:1686–1695. tion. In the study by Nitschke et al, several email@example.com 7. Duffas J-P, Suc B, Msika S, et al. A controlled significant clinicopathological differences randomized multicenter trial of pancreatogastros- tomy or pancreatojejunostomy after pancreatoduo- were demonstrated between the 3 groups Division of Digestive Surgery and denectomy. Am J Surg. 2005;189:720–729. (primary R0, secondary R0, R1), showing Liver Transplantation, Archet II Hospital 8. Topal B, Fieuws S, Aerts R, et al. Pancreaticoje- that R1 patients had more unfavorable University of Nice-Sophia-Antipolis junostomy versus pancreaticogastrostomy recon- prognostic characteristics (Ca 19–9 values, Nice, France struction after pancreaticoduodenectomy for T stage, nodal status, perineural invasion, pancreatic or periampullary tumours: a multicentre randomised trial. Lancet Oncol. 2013;14:655–662. tumor size, lymphovascular invasion). Tarek Debs, MD 9. Yeo CJ, Cameron JL, Maher MM, et al. A Primary R0 patients had the lower rate Division of Digestive Surgery and prospective randomized trial of pancreaticogas- of unfavorable features, and secondary Liver Transplantation, Archet II
Annals of Surgery – Wolters Kluwer Health
Published: Mar 1, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.
All for just $49/month
It’s easy to organize your research with our built-in tools.
All the latest content is available, no embargo periods.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud